Novartis reaffirms commitment to fighting malaria and recognizes the dedication of our people and partners.
The most lethal strain could be eliminated by 2030, but major hurdles remain.
Novartis announced the company’s financial results for the first quarter of 2019.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.